A look at Oscar Health Inc’s (OSCR) recent performance gives investors their first glimpse of hope.

Oscar Health Inc (NYSE: OSCR) kicked off on Monday, up 6.35% from the previous trading day, before settling in for the closing price of $17.33. Over the past 52 weeks, OSCR has traded in a range of $7.29-$23.79.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

During the last 5-year period, the sales growth of Healthcare Sector giant was 113.90%. While this was happening, its average annual earnings per share was recorded 103.35%. With a float of $173.48 million, this company’s outstanding shares have now reached $211.70 million.

Let’s determine the extent of company efficiency that accounts for 2400 employees. In terms of profitability, gross margin is 99.99%, operating margin of 0.72%, and the pretax margin is 0.44%.

Oscar Health Inc (OSCR) Insider Activity

Our next focus will be how large-scale investors are participating in this stock of the Healthcare Plans Industry. The insider ownership of Oscar Health Inc is 29.84%, while institutional ownership is 61.49%. The most recent insider transaction that took place on Dec 02 ’24, was worth 512,708. Before that another transaction happened on Dec 02 ’24, when Company’s Chief Legal Officer proposed sale 21,073 for $17.33, making the entire transaction worth $365,195.

Oscar Health Inc (OSCR) Earnings and Forecasts

In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.66 earnings per share (EPS), higher than consensus estimate (set at -0.7) by 0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.63 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 103.35% per share during the next fiscal year.

Oscar Health Inc (NYSE: OSCR) Trading Performance Indicators

Take a look at Oscar Health Inc’s (OSCR) current performance indicators. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.55. Likewise, its price to free cash flow for the trailing twelve months is 5.06.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.06, a number that is poised to hit -0.60 in the next quarter and is forecasted to reach 0.75 in one year’s time.

Technical Analysis of Oscar Health Inc (OSCR)

Looking closely at Oscar Health Inc (NYSE: OSCR), its last 5-days average volume was 3.26 million, which is a drop from its year-to-date volume of 3.42 million. As of the previous 9 days, the stock’s Stochastic %D was 72.47%. Additionally, its Average True Range was 1.30.

During the past 100 days, Oscar Health Inc’s (OSCR) raw stochastic average was set at 49.62%, which indicates a significant decrease from 92.76% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 92.90% in the past 14 days, which was higher than the 76.37% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $17.36, while its 200-day Moving Average is $17.44. However, in the short run, Oscar Health Inc’s stock first resistance to watch stands at $19.06. Second resistance stands at $19.68. The third major resistance level sits at $20.55. If the price goes on to break the first support level at $17.57, it is likely to go to the next support level at $16.70. Should the price break the second support level, the third support level stands at $16.08.

Oscar Health Inc (NYSE: OSCR) Key Stats

The company with the Market Capitalisation of 4.56 billion has total of 247,269K Shares Outstanding. Its annual sales at the moment are 5,863 M in contrast with the sum of -270,730 K annual income. Company’s last quarter sales were recorded 2,423 M and last quarter income was -54,600 K.